Schizophrenia with prominent catatonic features ('catatonic schizophrenia'). III. Latent class analysis of the catatonic syndrome

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 1, 2009, Pages 81-85

  Ungvari, Gabor S ^a   Goggins, William ^a   Leung, Siu Kau ^b   Lee, Edwin ^a   Gerevich, Jozsef ^c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CASTLE PEAK HOSPITAL   (Hong Kong)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

Catatonia; Latent class analysis (LCA); Schizophrenia

Indexed keywords

ADULT; ARTICLE; CATATONIA; CATATONIC SCHIZOPHRENIA; CHINESE; EXTRAPYRAMIDAL SYMPTOM; EXTRAPYRAMIDAL SYSTEM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; RATING SCALE; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL MODEL; SYMPTOMATOLOGY;

ADULT; COHORT STUDIES; HUMANS; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIA, CATATONIC; SEVERITY OF ILLNESS INDEX;

EID: 58149333440     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.10.010     Document Type: Article

References (58)

1. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov B.N., and Csaki F. (Eds). Proceedings of the 2nd Int. Symposium on Information Theory (1973), Akademiai, Budapest 267-281
2. APA. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
3. Andreasen N.C. The Scale for Assessment of Negative Symptoms (SANS) (1983), University of Iowa Press, Iowa City
4. Baca-Garcia E., Perez-Rodriguez M.M., Basurte-Villamor I., Fernandez del Moral A.L., Jimenez-Arriero M.A., Gonzalez de Rivera J.L., et al. Diagnostic stability of psychiatric disorders in clinical practice. Brit J Psychiatry 190 (2007) 21-216
5. Ban T.A. Chronic schizophrenias: a guide to Leonhard's classification. Compr Psychiatry 23 (1982) 155-169
6. Bleuler E. Dementia Praecox or the Group of Schizophrenias (1950), International University Press, New York
7. Barnes T.R.E. A rating scale for drug-induced akathisia. Brit J Psychiatry 154 (1989) 672-676
8. Bostroem A. In: Bumke O. (Ed). Katatone Storungen. Handbuch der Geisteskrankheiten vol. II (1928), Springer, Berlin 134-205
9. Braunig P., Kruger S., and Hoffler J. Verstarkung katatoner Symptomatik unter Neuroleptikatherapie. Nervenarzt 66 (1995) 379-382
10. Caroff S.N., and Ungvari G.S. Guest editorial. Psychiatr Ann 37 (2007) 7-9
11. Carroll B.T. The universal field hypothesis of catatonia and neuroleptic malignant syndrome. CNS Spectr 5 (2000) 26-33
12. Chalasani P., Healy D., and Morriss R. Presentation and frequency of catatonia in new admissions to two acute psychiatric admission units in India and Wales. Psychol Med 35 (2005) 1667-1675
13. Cottencin O., Thomas P., Vaiva G., Rascle C., and Goudemand M. A case of agitated catatonia. Pharmacopsychiatry 32 (1999) 38-40
14. Endicott J., Spitzer R.L., Fleiss J.L., and Cohen J. The Global Assessment Scale. Arch Gen Psychiatry 33 (1976) 766-771
15. Gelenberg A.J. Criteria for the diagnosis of catatonia. Am J Psychiatry 134 (1977) 462-463
16. Gelenberg A.J., and Mandel M.R. Catatonic reactions to high-potency neuroleptic drugs. Arch Gen Psychiatry 34 (1977) 947-950
17. Goodman W.K., Price H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., et al. The Yale-Brown Obsessive Compulsive Scale: I. Development, use and reliability. Arch Gen Psychiatry 46 (1989) 1006-1011
18. Guggenheim F.G., and Babigian H.M. Diagnostic consistency in catatonic schizophrenia. Schizophr Bull 11 (1974) 103-108
19. Guy W. NECDEU Assessment Manual for Psychopharmacology (1976), ADAMHA, US DHEW Publication (ADM), Rockville, MD 76-338
20. Hearst E.D., and Munoz R.A. Catatonia: its diagnostic validity. Dis. Nerv. Syst. 32 (1971) 453-456
21. Honigfeld G., and Klett C.J. The Nurses' Observation Scale for Inpatient Evaluation (NOSIE) - a new scale for measuring improvement in chronic schizophrenia. J Clin Psychol 21 (1965) 65-71
22. Jablensky A. Subtyping schizophrenia: implications for genetic research. Mol Psychiatry 11 (2006) 815-836
23. Kane J.M. Drug therapy - schizophrenia. N Engl J Med 334 (1996) 34-41
24. Kleist K., Leonhard K., and Schwab H. Die Katatonie auf Grund katamnestischer Untersuchungen. Zschr f d ges Neurol un Psychiatrie 168 (1940) 535-583
25. Kraepelin E. Psychiatrie (1899), Barth, Leipzig
26. Krueger S., Bagby M.R., Hoffler J., and Braunig P. Factor analysis of the Catatonia Rating Scale and catatonic symptom distribution across four diagnostic groups. Compr Psychiatry 44 (2003) 472-482
27. Lanza S.T., Collins L.M., Lemmon D.R., and Schafer J.L. PROC LCA: A SAS procedure for latent class analysis. Struct Equ Modeling 14 (2007) 671-694
28. Leonhard K. Aufteilung der endogenen Psychosen (1957), Akademie, Berlin
29. Leung S.K., Ungvari G.S., Ng F.S., Cheung H.K., and Leung T. Tardive dyskinesia in Chinese inpatients with chronic schizophrenia. Progr Neuro-Psychopharmacol Biol Psychiat 27 (2003) 1029-1036
30. Lykouras L., Oulis P., Daskalopoulou E., Psarros K., and Christodolou G.N. Clinical subtypes of schizophrenic disorders: a cluster analytic study. Psychopathology 34 (2001) 23-28
31. Liddle P.F. Commentary on the Modified Rogers Scale and the "conflict of paradigms" hypothesis. Brit J Psychiatry 158 (1991) 337-339
32. McKenna P., Lund C.E., Mortimer A.M., and Biggins C.A. Motor, volitional and behavioural disorders in schizophrenia. 2: The 'conflict of paradigms' hypothesis. Brit J Psychiatry 158 (1991) 328-336
33. Mimica N., Folnegovic-Smalc V., and Folnegovic Z. Catatonic schizophrenia in Croatia. Eur Arch Psychiatry Clin Neurosci 251 Suppl.1 (2001) 17-20
34. Morrison J.R. Catatonia: retarded and excited types. Arch Gen Psychiatry 28 (1973) 39-41
35. Munetz M.R., and Benjamin S. How to examine patients using the Abnormal Involuntary Movement Scale. Hosp Comm Psychiatry 39 (1988) 1172-1177
36. Northoff G. What catatonia can tell about "top-down modulation": a neuropsychiatric hypothesis. Brain Behav Sci 25 (2002) 555-604
37. Owens D.G.C., Johnstone E.C., and Frith C.D. Spontaneous involuntary disorders of movement - their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics. Arch Gen Psychiatry 39 (1982) 452-461
38. Peralta V., and Cuesta M.J. Negative, Parkinsonian, depressive and catatonic symptoms in schizophrenia: a conflict of paradigm revisited. Schizophr Res 40 (1999) 245-253
39. Peralta V., and Cuesta M.J. Motor features in psychotic disorders. II. Development of diagnostic criteria for catatonia. Schizophr Res 47 (2001) 117-126
40. Ponizovsky A.M., Grinsphoon A., Pugachev I., Nahon D., Ritsner M., and Abramowitz M.Z. Changes in stability of first-admission psychiatric diagnoses over 14 years, based on cross-sectional data at three time points. Isr J Psychiatry Relat Sci 43 (2006) 34-39
41. Rogers D. The motor disorders of severe psychiatric illness: a conflict of paradigms. Brit J Psychiatry 147 (1985) 221-232
42. Salokangas R.K., Honkonen T., Stengard E., Koivisto A.M., and Hietala J. Negative symptoms and neuroleptics in catatonic schizophrenia. Schizophr Res 59 (2003) 73-76
43. Schwartz G. Estimating the dimension of a model. Ann Statist 6 (1978) 461-464
44. Simpson G.M., and Angus J.W.S. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 45 Suppl. 212 (1970) 11-19
45. Stompe T., Ortwein-Swoboda G., Ritter K., Schanda H., and Friedmann A. Are we witnessing the disappearance of catatonic schizophrenia?. Compr Psychiatry 43 (2002) 167-174
46. Taylor M.A. Catatonia: a review of a behavioral neurologic syndrome. Neuropsychiatry Neuropsychol Behav Neurol 3 (1990) 48-72
47. Taylor D., Paton C., and Kerwin R. The Maudsley Prescribing Guidelines (2005-2006) (2005), Taylor & Francis, London- New York
48. Ungvari G.S., Chiu H.F.K., Chow L.Y., Lau B.S.T., and Tang W.K. Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study. Psychopharmacology 142 (1999) 393-398
49. Ungvari G.S., and Carroll B.T. Nosology. In: Caroff S.N., Mann S.C., Francis A., and Fricchione G.L. (Eds). Catatonia. From psychopathology to neurobiology (2004), American Psychiatric Publishing Inc., Washington 33-43
50. Ungvari G.S., Leung S.K., Ng F.S., Cheung H.K., and Leung T. Schizophrenia with prominent catatonic features ('catatonic schizophrenia'). I. Demographic and clinical correlates in the chronic phase. Prog Neuro-Psychopharmacol Biol Psychiatry 29 (2005) 27-38
51. Ungvari G.S., Goggins W., Leung S.K., and Gerevich J. Schizophrenia with prominent catatonic features ('catatonic schizophrenia'). II. Factor analysis of the catatonic syndrome. Prog Neuro-Psychopharmacol Biol Psychiatry 31 (2007) 462-468
52. Van der Heijden F.M., Tuinier S., Arts N.J., Hoogendron M.L., Kahn R.S., and Verhoeven W.M. Catatonia: disappeared or under-diagnosed?. Psychopathology 38 (2005) 3-8
53. Van Putten T. Why do schizophrenic patients refuse to take their drugs?. Arch Gen Psychiatry 31 (1974) 67-72
54. Weder N.D., Muralee S., Penland H., and Tampi R.R. Catatonia: a review. Ann Clin Psychiatry 20 (2008) 97-107
55. Williams J.B.W. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 45 (1988) 742-747
56. Wing J.K., and Freudenberg R.K. The response of severely ill chronic schizophrenia patients to social stimulation. Am J Psychiatry 117 (1961) 311-322
57. Woerner M.G., Mannuzza S., and Kane J.M. Anchoring the BPRS: an aid to improved reliability. Psychopharmacol Bull 24 (1988) 112-117
58. Wong E., Ungvari G.S., Leung S.K., and Tang W.K. Rating catatonia in patients with chronic schizophrenia: Rasch analysis of the Bush-Francis Catatonia Rating Scale. Int J Methods Psychiatr Res 16 (2007) 161-170